Funding for this research was provided by:
U.S. Department of Defense (W81XWH-17-C-0008, W81XWH-20-1-0869)
Harvard University (Milton Fund)
U.S. Department of Health & Human Services | NIH | National Eye Institute (P30 EY003790)
Article History
Received: 8 January 2021
Accepted: 23 November 2022
First Online: 30 November 2022
Competing interests
: Dr. Pate is the CEO of Coruna Medical, LLC, which has the exclusive licensing right to the Supersaturated Oxygen Emulsion. The remaining authors declare no competing interests.